War on Disease
War on Disease
Invite
Back to Treatments
Treatment
Tocilizumab
1
Conditions
86
Trials
15K
Participants
45%
Average Safety
Condition Evidence
COVID-19
86 trials Β· 15K participants
80% effectiveness Β· 45% safety
Tocilizumab | DFDA